INR 524.8
(2.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 72.75 Million | 63.45 Million | 59.41 Million | 54 Million | 105.53 Million |
Cost of Revenue | 24.6 Million | 22.49 Million | 22.88 Million | 17.92 Million | 50.19 Million |
Gross Profit | 48.15 Million | 40.96 Million | 36.52 Million | 36.08 Million | 55.33 Million |
Operating Expenses | 23.74 Million | 29.03 Million | 18.22 Million | 16.97 Million | 36.74 Million |
Selling, General and Administrative Expenses | 0.18 | 0.23 | 0.38 | 0.26 | 0.15 |
Research and Development Expenses | 0.33 | 0.19 | 0.50 | 0.39 | 0.16 |
Other Expenses | - | -38 Thousand | 11.3 Million | 2.08 Million | -2.01 Million |
Cost and Expenses | 46.62 Million | 51.52 Million | 41.11 Million | 34.89 Million | 86.94 Million |
Operating Income | 26.13 Million | 1.63 Million | 2.49 Million | 4000.00 | 5000.00 |
Interest Expense | - | 44 Thousand | 42 Thousand | 391 Thousand | 2.53 Million |
Income Tax Expense | 10.61 Million | 11.92 Million | 18.3 Million | 19.1 Million | 18.59 Million |
Earnings before Tax | 24 Million | 13.56 Million | 20.79 Million | 19.11 Million | 18.6 Million |
Net Income | 13.39 Million | 11.89 Million | 29.61 Million | 21.19 Million | 16.57 Million |
Earnings Per Share Basic | 9.57 | -2.99 Million | 7.19 Million | 7.07 Million | 1.22 Million |
Earnings Per Share Diluted | 9.57 | 14.88 Million | 22.39 Million | 14.11 Million | 15.34 Million |
Weighted Average Shares Outstanding | 1.4 Million | 10.34 | 15.56 | 9.80 | 10.66 |
Weighted Average Shares Outstanding (Diluted) | 1.4 Million | 10.34 | 15.56 | 9.80 | 10.66 |
Gross Margin | 0.66 | 0.65 | 0.61 | 0.67 | 0.52 |
EBIT Margin | 0.37 | 0.21 | 0.35 | 0.35 | 0.18 |
Profit Margin | 0.18 | 0.19 | 0.50 | 0.39 | 0.16 |
EBITDA | 27.28 Million | 13.56 Million | 20.79 Million | 19.11 Million | 18.6 Million |
Earnings Before Tax Margin | 0.36 | 0.03 | 0.04 | 0.00 | 0.00 |
Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Revenue | 18.55 Million | 72.75 Million | 21.59 Million | 18.65 Million | 14.63 Million | 19.57 Million |
Cost of Revenue | 8.34 Million | 24.6 Million | 8.55 Million | 6.26 Million | 3.77 Million | 8.11 Million |
Gross Profit | 10.21 Million | 48.15 Million | 13.04 Million | 12.38 Million | 10.85 Million | 11.45 Million |
Operating Expenses | -5.69 Million | 23.74 Million | 6.1 Million | 6.09 Million | 5.62 Million | 5.92 Million |
Selling, General and Administrative Expenses | - | - | - | - | - | - |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | -5.69 Million | -2.12 Million | -6.1 Million | -6.09 Million | -5.62 Million | -5.92 Million |
Cost and Expenses | 14.03 Million | 46.62 Million | 14.65 Million | 12.35 Million | 9.39 Million | 14.03 Million |
Operating Income | 4.52 Million | 26.13 Million | 6.93 Million | 6.29 Million | 5.23 Million | 5.53 Million |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | 1.7 Million | 10.61 Million | 1.74 Million | 1.53 Million | 1.31 Million | 6.01 Million |
Earnings before Tax | 4.52 Million | 24 Million | 6.94 Million | 6.29 Million | 5.23 Million | 5.53 Million |
Net Income | 2.81 Million | 13.39 Million | 5.13 Million | 4.78 Million | 3.94 Million | -478 Thousand |
Earnings Per Share Basic | 1.95 | - | 3.56 | 3.33 | 2.74 | -0.33 |
Earnings Per Share Diluted | 1.95 | - | 3.56 | 3.33 | 2.74 | -0.33 |
Weighted Average Shares Outstanding | 1.43 Million | 1.4 Million | 1.44 Million | 1.43 Million | 1.43 Million | 1.43 Million |
Weighted Average Shares Outstanding (Diluted) | 1.43 Million | 1.4 Million | 1.44 Million | 1.43 Million | 1.43 Million | 1.43 Million |
Gross Margin | 0.55 | 0.66 | 0.60 | 0.66 | 0.74 | 0.59 |
EBIT Margin | 0.25 | - | 0.33 | 0.35 | 0.38 | 0.30 |
Profit Margin | 0.15 | 0.18 | 0.24 | 0.26 | 0.27 | -0.02 |
EBITDA | 4.72 Million | - | 7.22 Million | 6.58 Million | 5.52 Million | 5.82 Million |
Earnings Before Tax Margin | 0.24 | 0.36 | 0.32 | 0.34 | 0.36 | 0.28 |
RANEHOLDIN
2168
S63
BIOCON
TRAW
YAK